524414
NORRIS
Start SIP
Invest Now
Start SIP in NORRIS
Performance
- Low
- ₹13
- High
- ₹15
- 52 Week Low
- ₹13
- 52 Week High
- ₹22
- Open Price₹14
- Previous Close₹14
- Volume979
- 50 DMA₹14.81
- 100 DMA₹15.44
- 200 DMA₹16.21
Investment Returns
- Over 1 Month -6.93%
- Over 3 Month -14.09%
- Over 6 Month -17.45%
- Over 1 Year -35.85%
Smart Investing Starts Here Start SIP with Norris Medicines for Steady Growth!
Norris Medicines Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -9.1
- PEG Ratio
- 0.1
- Market Cap Cr
- 14
- P/B Ratio
- -0.9
- Average True Range
- 1.22
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.38
- RSI
- 46.58
- MFI
- 74.3
Norris Medicines Financials
Norris Medicines Technicals
EMA & SMA
Current Price
₹13.96
-0.29
(-2.04%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹14.22
- 50 Day
- ₹14.81
- 100 Day
- ₹15.44
- 200 Day
- ₹16.21
Resistance and Support
13.91
- R3 16.54
- R2 15.65
- R1 14.80
- S1 13.06
- S2 12.17
- S3 11.32
Norris Medicines Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-14 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-08-14 | Quarterly Results | |
| 2025-05-28 | Audited Results | |
| 2025-02-13 | Quarterly Results & Others | Inter-alia, to consider 1. Requests from Mr. Nimish Bhishma Thakore, for reclassification from Promoter / Promoter Group into Public Category. 2. Other business matters. |
Norris Medicines F&O
About Norris Medicines
- NSE Symbol
- NORRIS
- BSE Symbol
- 524414
- ISIN
- INE744C01029
Similar Stocks to Norris Medicines
Norris Medicines FAQs
Norris Medicines share price is ₹13 As on 13 February, 2026 | 00:25
The Market Cap of Norris Medicines is ₹14 Cr As on 13 February, 2026 | 00:25
The P/E ratio of Norris Medicines is -9.1 As on 13 February, 2026 | 00:25
The PB ratio of Norris Medicines is -0.9 As on 13 February, 2026 | 00:25
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.